Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib
Yazar
Zhang, Lei
Ramchandren, Radhakrishnan
Robertson, Michael J.
Avivi, Irit
Rowe, Jacob M.
Herbrecht, Raoul
Van Hoof, Achiel
Egyed, Miklos
Besisik, Sevgi
Witzig, Thomas E.
Heise, Carla
Fu, Tommy
Cicero, Sherri
Goy, Andre
Williams, Michael E.
Drach, Johannes
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]